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Abstract 
The regulation of aromatase (estrogen synthase) activity of cultured stromal vascular cells from human breast adipose tissue by cortisol, db-cAMP 
and growth factors was studied in a serum-free culture system. While PDGF-BB alone inhibited the effect of db-CAMP on aromatase induction, it 
stimulated aromatase activity in the presence of cortisol with or without db-cAMP. In the presence of 1 PM insulin consistently higher aromatase 
activities were found as compared to 1 nM insulin. In contrast to PDGF-BB, bFGF led to an increase of aromatase activity only in the presence 
of both cortisol and db-cAMP. 
Key woruk Aromatase; Cortisol; PDGF; bFGF; Breast adipose tissue (human) 
1. Introduction 
Stromal vascular cells from human adipose tissue, due 
to their high aromatase activity, are able to produce large 
amounts of estrogens by aromatization of androgens 
[l-3]. They can be kept in culture and may be used to 
study the regulation of extraovarian estrogen formation. 
In these cells synthetic analognes of cyclic AMP are in- 
ducers of aromatase activity, however they have been 
reported to act only under serum-free culture conditions 
[4]. Phorbol esters potentiate the action of db-CAMP, 
whereas tumor necrosis factor, transforming growth fac- 
tors and , interleukin-1, epidermal growth factor and 
PDGF have been reported to be strong inhibitors [5]. 
Glucocorticoids also are powerful inducers of aroma- 
tase. Their action seems to depend on the presence of as 
yet unidentified factors present in serum, as they are 
ineffective in its absence [6]. As the functional integrity 
of the epithelial cells of the human breast depends on the 
presence of estrogens, the ability of the stromal cells from 
mammary adipose tissue to produce estrogens due to 
their aromatase activity (for review see [5]) could account 
for at least some part of their estrogen supply. 
Significantly higher estradiol concentrations were ob- 
served in malignant as compared to normal breast tissues 
in pre- and postmenopausal women [7]. In addition de- 
spite of large differences in peripheral plasma estrogen 
concentrations in the pre- versus the postmenopausal 
state, similar estradiol concentrations were found in ma- 
lignant breast tissue from pre- as well as from postmeno- 
pausal women. These observations upport the idea, that 
there exist local sources of estrogens within the human 
breast which might play an important role for the devel- 
opment of breast cancer [&lo]. The finding of elevated 
aromatase activity in the adipose tissue localized near 
breast tumors [l 1,121 implicate, that tumor cells produce 
factors, which act as inducers of aromatase activity. A 
large variety of growth factors, including PDGF and 
bFGF, is released by breast cancer cells (for review see 
[13,14]), often without any known effect on the cancer 
cells themselves. To test whether there exists a paracrine 
mechanism for aromatase induction based on growth 
factors, we studied the regulation of aromatase activity 
in stromal vascular cells of human breast adipose tissue 
by some of these factors. We show here, that under 
serum-free culture conditions the induction of aromatase 
activity by cortisol treatment of stromal vascular cells 
depends on the addition of either PDGF-BB or bFGF 
together with db-CAMP. 
*Corresponding author. Fax: (49) (941) 9432 474. 
2. Materials and methods 
2.1. Cells and cell culture 
Abbreviations: PDGF, platelet-derived growth factor; bFGF, basic 
fibroblast growth factor; cyclic AMP, adenosine 3’:5’-cyclic mono- 
Human adipose tissue for the preparation of stromal vascular cells 
phosphate; db-cAMP, N6,2’-O-dibutyryladenosine 3’:S-cyclic mono- 
was obtained during plastic breast surgery from healthy women with 
an age of 25-33 years. The preparation of stromal vascular cells was 
phosphate; SF-medium, serum-free medium; FCS, fetal calf serum. performed essentially as described earlier [ 15,161. Cells were seeded at 
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a density of 10000 cells/cm2 in 25cmz Falcon flasks after isolation and 
in 24-well plates after one passage for subcultivation. They were grown 
to confluence in medium 199 with Earle’s salts containing penicillin 
(100 U/ml), streptomycin (0,l mg/ml) and 10% fetal calf serum, which 
was replaced three times a week. For experiments under serum-free 
conditions, cells were pretreated with serum-free medium (SF-medium) 
consisting of Dulbecco’s modified Eagle’s medium and Ham’s F12 
medium in a ratio of 3:l (both without Phenol red) supplemented with 
penicillin (100 U/ml), streptomycin (0.1 mg/ml), transferrin (2 j&ml), 
pantothenate (17 PM), biotin (1 PM). Insulin was added in a concentra- 
tion of either 1 nM or 1 PM as indicated. Pretreatment was done by 
changing media three times within 48 h to get total depletion of serum 
components. During culture cells were kept in a humidified atmosphere 
with 5% CO2 at a temperature of 37°C. 
2.2. Induction of aromatase and assay of aromatase activity 
If not indicated otherwise confluent cells were kept in SF-medium for 
2 days prior to the induction of aromatase activity. After that period, 
growth factors in concentrations as indicated were added with or with- 
out cortisol (1 PM) and db-CAMP (1 mM) respectively. 18 h later 
[ 1/?,2/J-3H]testosterone wasadded to the cells in a concentration of 150 
nM (3 @i/well). After 6 h the incorporation of ‘H-label in H,O was 
measured essentially as described [3,16]. Aromatase activity is given as 
pmol testosterone used/ 6 h x mg protein calculated according to [17]. 
Cellular protein was determined by an improved protocol of the 
method of Bradford [18], described by Peterson [ 191. 
2.3. Materials 
Cell culture media were from Biochrom, Berlin, Biotin, Norit A, 
Dextran and Serva Blue G-250 from Serva, Heidelberg, and [l/3,@- 
3H]testosterone from DuPont, Dreieich. Insulin was a generous gift 
from Dr. Brocks, Farbwerke Hoechst AG, Frankfurt. Recombinant 
PDGF-BB and bFGF were obtained from BTS, St&on-Rot. All other 
chemicals were of analytical grade and purchased from Sigma, Munich 
or Merck AG. Darmstadt. 
a 
Pretreatment: FCS 
Induction: FCS 
Insulin: 
b 
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2.4. Statistical analysis 
Analysis of aromatase activities induced by different agents was 
performed using the t-test for comparison of means. Differences were 
considered statistically significant at P < 0.05. 
3. Results 
As has been shown previously, stromal vascular cells 
from subcutaneous abdominal and breast adipose tissue 
respectively cultured in the presence of 10% FCS respond 
to cortisol with an approximately 5- to 7-fold increase of 
the specific aromatase activity [6,16] (Fig. 1, panel a). As 
the use of a serum-free medium is necessary for studies 
of the influence of growth factors on the induction of 
aromatase activity, the influence of pretreatment of 
stromal vascular cells with serum-free medium on aro- 
matase induction was studied. Stromal vascular cells 
grown to confluence in medium 199 containing 10% FCS 
were pretreated for 48 h by incubation in SF-medium 
containing either 1 nM or 1 ,uM insulin. When, during 
the subsequent aromatase induction and assay, medium 
199 supplemented with 10% FCS was used, no signifi- 
cant difference to cells without pretreatment under 
serum-free conditions could be observed (Fig. 1, panels 
a,b,d). db-CAMP had no effect on aromatase induction 
when added alone or in combination with cortisol. 
c 
SF-medium SF-medium 
FCS SF-medium 
1 nM 1 nM 
T 
d 
SF-medium 
FCS 
1 IrM 
e 
SF-medium 
SF-medium 
1 +M 
Fig. 1. Influence of serum deprivation on the induction of aromatase activity. Human breast adipose tissue stromal cells were grown to confluence 
in the presence of FCS and pretreated for 48 h prior to aromatase induction with medium containing 10% FCS (a) or with SF-medium containing 
either 1 nM (b,c) or 1 pM (d,e) insulin. The subsequent aromatase induction was carried out in the presence of either 10% FCS (a,b,d) or SF-medium 
containing the same insulin concentrations as during the pretreatment phase (c,e) by addition of 1 PM cortisol (m), 1 mM db-CAMP (8) or cortisol 
together with db-CAMP (@a); (0) induction without additions. Results are means of duplicate assays from at least 4 independent experiments & S.E.M. 
Differences ignificant (P < 0.05) to the respective values without cortisol (*), without db-CAMP (o), without FCS during the induction period (+) 
or to the values obtained in the presence of 1 nM insulin (#). 
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When however serum-free conditions were maintained 
during the test period, in the presence of insulin in a 
physiological concentration the effect of cortisol on aro- 
matase activity was nearly completely abolished (Fig. 1, 
panel c). In the presence of 1 ,uM insulin cortisol was able 
to induce aromatase activity, but to a significantly lower 
extent than in the presence of FCS (Fig. 1, panel e). In 
addition, db-CAMP led to a moderate increase of aroma- 
tase activity, which was statistically significant in cul- 
tures treated with 1 nM but not with 1 ,uM insulin (Fig. 
1, panels c,e). Cortisol and db-CAMP given simultane- 
ously to cultures under serum-free conditions were able 
to increase aromatase activity to values exceeding the 
activities found when cortisol or db-CAMP were added 
alone. This rise in activity was not significant when the 
effects of db-CAMP and db-CAMP together with cortisol 
in the presence of 1 nM insulin were compared. In the 
presence of 1 PM insulin the combination of db-CAMP 
together with cortisol was equally effective as cortisol in 
the presence of serum. 
In a serum-free culture system aromatase activity of 
stromal vascular cells increased after the addition of cor- 
tisol, when recombinant PDGF-BB was added to the 
medium. The effect of PDGF was dose dependent with 
a half maximal effective concentration of about lo-” M 
(Fig. 2, panels a,b). 
The increase in aromatase activity due to treatment 
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with PDGF-BB together with cortisol was dependent on 
the concentration of insulin. At a supraphysiological 
concentration (1 PM) significantly higher aromatase ac- 
tivities were obtained as compared to cultures treated 
with physiological insulin concentrations (1 nM) or with- 
out insulin (data not shown). 
The effect of db-CAMP in the presence of various con- 
centrations of PDGF is strongly affected by cortisol: in 
the absence of cortisol aromatase induction was sup- 
pressed by PDGF in a dose dependent manner (statisti- 
cally significant in the presence of 1 nM insulin), the 
concentration of half maximal inhibition of db-CAMP 
induced aromatase activity was about 10-i’ M. This in- 
hibitory effect of PDGF on db-CAMP mediated aroma- 
tase induction was reversed in the presence of cortisol. 
The values obtained by the combination of cortisol, 
PDGF and db-CAMP always were significantly higher 
than those obtained in the presence of cortisol and 
PDGF for all PDGF concentrations tested at 1 nM and 
1 PM insulin. 
Supraphysiological insulin concentrations resulted in 
significantly elevated aromatase activities when the val- 
ues measured after induction with PDGF and cortisol 
with and without db-CAMP were compared with the re- 
spective values at physiological insulin concentrations. 
bFGF in the same concentration range as PDGF-BB 
had no effect on aromatase activity of stromal vascular 
1 nM insulin 1 PM 
---I ” ” T 
a : PDGF-BE 
d : bFGF ,/-’ 
Growth factor concentration (mol/l) 
Fig. 2. Influence of PDGF-BB and bFGF on aromatase induction. Confluent human breast adipose tissue stromal vascular cells were pretreated 
in SF-medium and aromatase activity was induced under serumfree conditions as described in section 2. The experiments were done in the presence 
of physiological (1 nM, panels a,c) or supraphysiological(1 pM, panels b,d) insulin concentrations using either recombinant human PDGF-BB (panels 
a,b) or bFGF (panels c,d) as growth factors. Aromatase activity was determined without further additions (0) or in the presence of 1 ,uM cortisol 
(0). 1 mM db-cAMP (0) or cortisol together with db-cAMP (w). The results represent the means of duplicate assays from 4 independent experiments 
f S.E.M. Information regarding the significance of differences are given in the text. 
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cells, neither alone nor together with cortisol. However 
the failure of bFGF to increase aromatase activity to- 
gether with cortisol could be overcome by addition of 
db-CAMP (Fig. 2, panels c,d). Again treatment of cul- 
tures with 1 ,uM insulin resulted in higher aromatase 
activities as compared to treatment with 1 nM. An inhib- 
itory effect of bFGF on db-CAMP induced aromatase 
activity was observed only when 1 nM insulin was pres- 
ent. 
4. Discussion 
To our knowledge we present in this paper the first 
data on the regulation of aromatase activity in breast 
adipose tissue stromal cells. Like in subcutaneous 
stromal vascular cells kept under serum-free culture con- 
ditions [20], growth factors inhibit, in the absence of 
cortisol and at physiological concentrations of insulin, 
aromatase induction by db-CAMP. In serum-free cul- 
tures, an effect of cortisol on aromatase activity was 
observed when PDGF-BB was added. This might indi- 
cate that PDGF or a substance with a similar mode of 
action could be the serum component necessary for the 
cortisol effect. At the maximal effective concentration of 
PDGF-BB even higher aromatase activities were ob- 
tained as compared to incubations with 10% FCS. Addi- 
tion of db-CAMP together with cortisol at all PDGF-BB 
concentrations used consistently led to higher aromatase 
activities as compared to cultures kept without db- 
CAMP. 
With respect to the receptor type used and the mode 
of action, PDGF and bFGF share some similarities [21]. 
Despite this fact, bFGF was not able to support the 
cortisol effect on aromatase activity in a similar way as 
PDGF or serum. At all FGF-concentrations tested, cor- 
tisol together with db-CAMP was necessary to get an 
increase of aromatase activity in stromal vascular 
cells. 
These results indicate that aromatase activity of 
stromal vascular cells from breast adipose tissue is under 
multifactorial control. Glucocorticoids alone are not ef- 
fective, although glucocorticoid responsive elements 
have been detected in the aromatase gene [22]. The fact 
that PDGF, which alone, like cortisol, has no influence 
on aromatase activity, together with cortisol leads to an 
increase of aromatase activity indicates, that a tyrosine 
kinase linked pathway is involved in aromatase activa- 
tion. When bFGF is used instead of PDGF-BB, db- 
CAMP together with cortisol has to be added to cultures 
in order to get an aromatase activation. This is sugges- 
tive for an additional participation of cyclic AMP. The 
difference in the action of PDGF and FGF respectively 
could be explained by the speculation, that stromal vas- 
cular cells respond to PDGF, but not to FGF with an 
increase of cyclic AMP. Alternatively CAMP-analogues 
like db-CAMP might lead to an activation of the same 
downstream signalling molecules as PDGF does in the 
presence of cortisol, whereas bFGF would lack the pos- 
sibility of activating this signalling pathway. 
The complexity of regulation of aromatase activity in 
adipose tissue stromal cells is obvious, when the effect of 
growth factors and db-CAMP at physiological insulin 
concentrations in the absence and in the presence of 
cortisol are compared. The presence of glucocorticoid 
seems to be a prerequisite for a switch in the mode of 
action of growth factors, as their inhibitory effect in the 
absence of cortisol turns into a strong stimulatory effect 
in its presence. 
The fact finally, that in the presence of micromolar 
insulin concentrations consistently higher aromatase ac- 
tivities were observed as compared to cultures at physio- 
logical insulin concentrations indicates, that IGF-I could 
be involved in the regulation of aromatase activity. Lue- 
prasitsakul et al. [23] recently were able to demonstrate 
a small increase of aromatase activity of subcutaneous 
stromal vascular cells by high concentrations of IGF-I 
in the presence of serum and dexamethasone. Mahen- 
droo et al have shown very recently that different promo- 
tors for the aromatase gene exist in stromal vascular cells 
from various sources and that the usage of the promotors 
depends on the hormonal treatment of the cells [24]. By 
RACE-PCR techniques they could demonstrate that the 
S-untranslated regions of aromatase gene transcripts in 
stromal vascular cells differ, when RNA from cells 
treated with dexamethasone and serum was compared 
with RNA from db-CAMP treated cells kept in the ab- 
sence of serum. One could speculate from our findings 
that PDGF is important for the choice of the cortisol- 
dependent promotor. 
The results presented here strongly support the hy- 
pothesis, that tumor cells are able to induce elevated 
aromatase activity in surrounding adipose tissue by a 
paracrine mechanism. Whether PDGF is the inducing 
agent provided by tumors in vivo has to be demon- 
strated. However, there might exist several still unknown 
factors, which are able to replace PDGF [16]. In view of 
our results one can speculate, that PDGF might be (the 
or one of) the serum component(s), responsible for glu- 
cocorticoid induction of aromatase. The increase of aro- 
matase activity in adipose tissue with age of patients 
observed by Cleland et al. [25] could then be explained 
as a result of an increase in PDGF-receptor numbers on 
stromal cells or of higher PDGF concentrations availa- 
ble in the tissue. 
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